collection
https://read.qxmd.com/read/27007094/clinical-practice-guideline-management-of-acute-pancreatitis
#1
REVIEW
Joshua A Greenberg, Jonathan Hsu, Mohammad Bawazeer, John Marshall, Jan O Friedrich, Avery Nathens, Natalie Coburn, Gary R May, Emily Pearsall, Robin S McLeod
There has been an increase in the incidence of acute pancreatitis reported worldwide. Despite improvements in access to care, imaging and interventional techniques, acute pancreatitis continues to be associated with significant morbidity and mortality. Despite the availability of clinical practice guidelines for the management of acute pancreatitis, recent studies auditing the clinical management of the condition have shown important areas of noncompliance with evidence-based recommendations. This underscores the importance of creating understandable and implementable recommendations for the diagnosis and management of acute pancreatitis...
April 2016: Canadian Journal of Surgery. Journal Canadien de Chirurgie
https://read.qxmd.com/read/26219482/cirrhosis-a-practical-guide-to-management
#2
JOURNAL ARTICLE
Raymond S Koff
No abstract text is available yet for this article.
July 25, 2015: Gastroenterology
https://read.qxmd.com/read/26303675/towards-a-systems-view-of-ibs
#3
REVIEW
Emeran A Mayer, Jennifer S Labus, Kirsten Tillisch, Steven W Cole, Pierre Baldi
Despite an extensive body of reported information about peripheral and central mechanisms involved in the pathophysiology of IBS symptoms, no comprehensive disease model has emerged that would guide the development of novel, effective therapies. In this Review, we will first describe novel insights into some key components of brain-gut interactions, starting with the emerging findings of distinct functional and structural brain signatures of IBS. We will then point out emerging correlations between these brain networks and genomic, gastrointestinal, immune and gut-microbiome-related parameters...
October 2015: Nature Reviews. Gastroenterology & Hepatology
https://read.qxmd.com/read/26284597/diagnostic-and-prognostic-microbial-biomarkers-in-inflammatory-bowel-diseases
#4
REVIEW
Marla Dubinsky, Jonathan Braun
The microbiome plays multifaceted roles in the pathogenesis of inflammatory bowel diseases (IBD). Accordingly, the clinical challenge of patient heterogeneity in disease phenotype and response to treatment should in part be addressed by biomarkers that detect the host response to microbiota, and the levels of microbial taxa and products eliciting the host response in susceptible individuals. Molecular analysis has revealed much evidence for microbial taxonomic membership and microbial products in association with IBD, but their utility as clinical biomarkers is still in its infancy...
October 2015: Gastroenterology
https://read.qxmd.com/read/26303132/acg-clinical-guideline-diagnosis-and-management-of-small-bowel-bleeding
#5
JOURNAL ARTICLE
Lauren B Gerson, Jeff L Fidler, David R Cave, Jonathan A Leighton
Bleeding from the small intestine remains a relatively uncommon event, accounting for ~5-10% of all patients presenting with gastrointestinal (GI) bleeding. Given advances in small bowel imaging with video capsule endoscopy (VCE), deep enteroscopy, and radiographic imaging, the cause of bleeding in the small bowel can now be identified in most patients. The term small bowel bleeding is therefore proposed as a replacement for the previous classification of obscure GI bleeding (OGIB). We recommend that the term OGIB should be reserved for patients in whom a source of bleeding cannot be identified anywhere in the GI tract...
September 2015: American Journal of Gastroenterology
https://read.qxmd.com/read/26148292/in-the-clinic-gastroesophageal-reflux-disease
#6
REVIEW
Ian G Harnik
This issue provides a clinical overview of gastroesophageal reflux disease, focusing on diagnosis, treatment, and practice improvement. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including ACP Smart Medicine and MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine editors develop In the Clinic from these primary sources in collaboration with the ACP's Medical Education and Publishing divisions and with the assistance of science writers and physician writers...
July 7, 2015: Annals of Internal Medicine
https://read.qxmd.com/read/26122478/secretory-diarrhoea-mechanisms-and-emerging-therapies
#7
REVIEW
Jay R Thiagarajah, Mark Donowitz, Alan S Verkman
Diarrhoeal disease remains a major health burden worldwide. Secretory diarrhoeas are caused by certain bacterial and viral infections, inflammatory processes, drugs and genetic disorders. Fluid secretion across the intestinal epithelium in secretory diarrhoeas involves multiple ion and solute transporters, as well as activation of cyclic nucleotide and Ca(2+) signalling pathways. In many secretory diarrhoeas, activation of Cl(-) channels in the apical membrane of enterocytes, including the cystic fibrosis transmembrane conductance regulator and Ca(2+)-activated Cl(-) channels, increases fluid secretion, while inhibition of Na(+) transport reduces fluid absorption...
August 2015: Nature Reviews. Gastroenterology & Hepatology
https://read.qxmd.com/read/26116527/the-art-and-science-of-diagnosing-and-managing-drug-induced-liver-injury-in-2015-and-beyond
#8
REVIEW
James H Lewis
Drug-induced liver injury (DILI) remains a leading reason why new compounds are dropped from further study or are the subject of product warnings and regulatory actions. Hy's Law of drug-induced hepatocellular jaundice causing a case-fatality rate or need for transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver Injury Network. It serves as the basis for stopping rules in clinical trials and in clinical practice. Because DILI can mimic all known causes of acute and chronic liver disease, establishing causality can be difficult...
November 2015: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/25869391/acg-clinical-guideline-primary-sclerosing-cholangitis
#9
JOURNAL ARTICLE
Keith D Lindor, Kris V Kowdley, M Edwyn Harrison
Primary sclerosing cholangitis is a chronic cholestatic liver disease that can shorten life and may require liver transplantation. The cause is unknown, although it is commonly associated with colitis. There is no approved or proven therapy, although ursodeoxycholic acid is used by many on an empiric basis. Complications including portal hypertension, fat-soluble vitamin deficiency, metabolic bone diseases, and development of cancers of the bile duct or colon can occur.
May 2015: American Journal of Gastroenterology
https://read.qxmd.com/read/23261064/american-gastroenterological-association-medical-position-statement-on-constipation
#10
JOURNAL ARTICLE
Adil E Bharucha, Spencer D Dorn, Anthony Lembo, Amanda Pressman
No abstract text is available yet for this article.
January 2013: Gastroenterology
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.